Abstract
A microsponge delivery system (MDS) is a cutting-edge and distinctive method of structured drug delivery. Controlled drug delivery is now possible with the use of microsponge technology. MDS consists of porous microspheres with a substantially porous structure and a very small spherical shape, ranging in size from 5 to 300 microns. MDS is typically used to administer medications through topical channels, but new research has demonstrated the promise of this technique for parenteral, oral, and ocular drug delivery. While reducing the drug's side effects, MDS can readily change the pharmaceutical release shape and enhance formulation stability. Reaching the highest peak plasma concentration in the blood is the main goal of microsponge medication delivery. The most notable quality of MDS is their ability to self-sterilize. MDS is employed in countless studies as an anti-allergic, anti-mutagenic, and non-irritant. This review discusses formulation, eligibility requirements for medications to be included in MDS, formulation processes, evaluation criteria, and the function of MDS in the treatment of various illnesses. In the future, while researching MDS in other illnesses, this review will be quite helpful.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
